FY2025 · ended Dec 31, 2025 · Revenue $89.10M, +2.7% YoY · Filed Mar 31, 2026
Vaso Corporation (VASO) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $89.1 million and net income of $1.6 million. As of Jun 30, 2026 it held $38.3 million in cash and investments and $1.6 million in total debt.
Revenue (TTM)
$89.61M
+31.3% vs year-ago TTM
Net income (TTM)
$2.50M
+924.4% vs year-ago TTM
Operating cash flow (TTM)
$7.86M
+0.9% vs year-ago TTM
Free cash flow
$13.85M
+87.2% vs prior year
EPS (TTM)
$0.01
+923.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
175.95M
+0.1% vs prior year
Net cash
$36.65M
as of Jun 30, 2026
Operating margin
-2.7%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- VASO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plainview, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 839087
- Former names
- VASOMEDICAL, INC (until Sep 23, 2016); VASOMEDICAL INC (until May 15, 2012)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $89.1M | $86.8M | $81.0M | $79.3M | $75.6M |
| Operating income | -$2.9M | $285,000 | $4.2M | $6.5M | $2.8M |
| Net income | $1.6M | $951,000 | $4.8M | $11.3M | $6.1M |
| Diluted EPS | $0.01 | $0.01 | $0.03 | — | — |
| Operating cash flow | $9.3M | $3.3M | $5.3M | $14.4M | $7.8M |
| Free cash flow | — | — | — | $13.8M | $7.4M |
| Total assets | $88.3M | $82.9M | $75.8M | $71.6M | $52.4M |
| Stockholders' equity | $29.4M | $27.7M | $26.8M | $22.1M | $11.1M |
| Cash and investments | $35.0M | $26.3M | $14.0M | $21.2M | $7.7M |
| Total debt | $1.5M | $2.4M | $2.0M | $1.8M | $1.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K/A | Amended current report | Aug 6, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 23, 2026 | Jul 23, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
May 8, 2026 | May 4, 2026 |
All 508 Vaso Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.